Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases
Pharmaceuticals · 29.11.2023 · 16 (12) · 1660
DOI: 10.3390/ph16121660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.11.2023. Verfasst von Miglena Milusheva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anti-inflammatory drugs are used to relieve pain, fever, and inflammation while protecting the cardiovascular system. However, the side effects of currently available medications have limited their usage. Due to these adverse effects, there is a significant need for new drugs. The current trend of research has shifted towards the synthesis of novel anthranilic acid hybrids as anti-inflammatory agents. Phenyl- or benzyl-substituted hybrids exerted very good anti-inflammatory effects in preventing albumin denaturation. To confirm their anti-inflammatory effects, additional ex vivo tests were conducted. These immunohistochemical studies explicated the same compounds with better anti-inflammatory potential. To determine the binding affinity and interaction mode, as well as to explain the anti-inflammatory activities, the molecular docking simulation of the compounds was investigated against human serum albumin. The biological evaluation of the compounds was completed, assessing their antimicrobial activity and spasmolytic effect. Based on the experimental data, we can conclude that a collection of novel hybrids was successfully synthesized, and they can be considered anti-inflammatory drug candidates—alternatives to current therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Bioorganic Chemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Department of Chemistry, Faculty of Science, University of Sistan and Baluchestan, Zahedan P.O. Box 98135-674, Iran.
- Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
- Department of Microbiology, Technological Faculty, University of Food Technologies, 4002 Plovdiv, Bulgaria.
ORCID-Profile: Miglena Milusheva, Mina Todorova, Vera Gledacheva, Iliyana Stefanova, Mehran Feizi-Dehnayebi, Mina Pencheva, Paraskev Nedialkov, Yulian Tumbarski, Velichka Yanakieva, Stoyanka Nikolova
Zitieren
APA
Milusheva, M., Todorova, M., Gledacheva, V., Stefanova, I., Feizi-Dehnayebi, M., Pencheva, M., Nedialkov, P., Tumbarski, Y., Yanakieva, V., Tsoneva, S., & Nikolova, S. (2023). Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals, 16(12), 1660. https://doi.org/10.3390/ph16121660
Vancouver
Milusheva M, Todorova M, Gledacheva V, Stefanova I, Feizi-Dehnayebi M, Pencheva M, et al. Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases. Pharmaceuticals. 2023;16(12):1660. doi:10.3390/ph16121660
BibTeX
@article{Milusheva2023,
author = {Milusheva, Miglena and Todorova, Mina and Gledacheva, Vera and Stefanova, Iliyana and Feizi-Dehnayebi, Mehran and Pencheva, Mina and Nedialkov, Paraskev and Tumbarski, Yulian and Yanakieva, Velichka and Tsoneva, Slava and Nikolova, Stoyanka},
title = {Novel Anthranilic Acid Hybrids—An Alternative Weapon against Inflammatory Diseases},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {12},
pages = {1660},
doi = {10.3390/ph16121660}
}
EUVIMED